Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets
Ayla Guven1,2, Roua A Al-Rijjal3, Huda A BinEssa3
1Department of Pediatric, Amasya University Medical Faculty, Amasya, Turkey.
Insights
Genetic defects causing hypophosphataemic rickets (HR) were investigated. PHEX mutations are the most common cause in the Turkish population, with novel and de novo mutations frequently identified, expanding the known mutation spectrum for HR.
Area of Science:
- Genetics
- Molecular Biology
- Pediatric Endocrinology
Background:
- Hypophosphataemic rickets (HR) is a rare inherited disorder characterized by renal phosphate wasting.
- It results from mutations in genes including PHEX, FGF23, DMP1, ENPP1, CLCN5, or SLC34A3.
Purpose of the Study:
- To identify the underlying genetic causes of hypophosphataemic rickets in patients.
- To analyze mutations in key genes associated with HR.
Main Methods:
- Genomic DNA from nine families was analyzed using PCR sequencing and copy number analysis.
- The entire coding regions of PHEX, FGF23, DMP1, ENPP1, CLCN5, and SLC34A3 were screened for mutations.
Main Results:
- PHEX mutations were found in 12 patients (seven families), including five novel mutations.
- Novel mutations in CLCN5 and FGF23 were identified in two patients.
- Several de novo mutations were observed, and the breakpoints of two novel PHEX mutations were characterized.
Conclusions:
- Novel and de novo mutations are common in hypophosphataemic rickets.
- PHEX mutations remain the most frequent genetic cause in the Turkish population.
- Gene copy number analysis is recommended for patients with negative sequencing results.
Context:
Hypophosphataemic rickets (HR) is a group of rare hereditary renal phosphate wasting disorders caused by mutations in PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3.
Objective:
To investigate underlying genetic defects in patients with hypophosphataemic rickets.
Methods:
We analysed genomic DNA from nine unrelated families for mutations in the entire coding region of PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3 by PCR sequencing and copy number analysis.
Results:
A total of 14 patients were studied. PHEX mutations were identified in 12 patients from seven families. Five of them were novel mutations present in eight patients: c.154G>T (p.E52*), c.401_402insGCCAAA (p.Q134_K135insPK), c.1600C>T (p.P534S), g.22016715_22056805del (40-kb deletion including promoter and exons 1-3) and c.2242_2243delCT (p.L748 fs*48). Four patients had previously reported mutations: c.1768+1G>A and c.1807G>A (p.W602*). Novel CLCN5 (c.1205G>A, p.W402*) and FGF23 (c.526C>G, p.R176G) mutations were found in two patients from the remaining two families. Many of the mutations were de novo: c.154G>T and c.2242_2243delCT in PHEX and c.526C>G in FGF23. Furthermore, we characterized the breakpoint of the novel PHEX g.22016715_22056805del and the c.2242_2243delCT, which is 6 bp from the stop codon, resulting in a frameshift and extension of the reading frame by 42 amino acids.
Conclusions:
Novel and de novo mutations are frequent and PHEX mutations are still the most common genetic defects in the Turkish population. Gene copy number analysis should be considered in patients with negative results by conventional PCR-based sequencing analysis. The current study further expands the mutation spectrum underlying HR.
More Related Videos
Related Concept Videos
Introduction to Electrolytes
Role of Sodium
One...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...


